NL
NL PHARMA
BV0661.907.808
Limit reached
You have reached your following limit. Please upgrade your account to follow more companies.
Ratio | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|
Summary | ||||
Credit limit |
€
6K
57.48%
|
€
4K
5.59%
|
€
4K
34%
|
€
3K
|
Profit |
€
29K
305.4%
|
€
7K
-33.82%
|
€
11K
80.61%
|
€
6K
|
Equity |
€
47K
19.31%
|
€
39K
-7.08%
|
€
42K
34%
|
€
32K
|
Gross margin |
€
40K
113.34%
|
€
19K
-45.45%
|
€
35K
37.54%
|
€
25K
|
Dividends |
€
9K
|
|||
Profitability | ||||
EBITDA |
€
38K
119.95%
|
€
17K
-40.27%
|
€
29K
30.08%
|
€
23K
|
EBIT |
€
29K
305.4%
|
€
7K
-62.77%
|
€
19K
58.21%
|
€
12K
|
Net profit |
€
17K
657.99%
|
€
-3K
-127.92%
|
€
11K
80.61%
|
€
6K
|
Capex |
€
9K
0%
|
€
9K
-19.27%
|
€
11K
8.51%
|
€
10K
|
Liquidity | ||||
Cash |
€
4K
-9.75%
|
€
4K
-59.43%
|
€
10K
424.08%
|
€
2K
|
Cashflow |
€
26K
256.65%
|
€
7K
-64.65%
|
€
21K
27.72%
|
€
16K
|
Current ratio |
1.51
23.77%
|
1.22
3.39%
|
1.18
28.26%
|
0.92
|
Quick ratio |
1.61
31.97%
|
1.22
0.83%
|
1.21
22.22%
|
0.99
|
Working capital |
€
18K
115.21%
|
€
8K
-2.87%
|
€
8K
377.25%
|
€
-3K
|
Working capital ratio |
1.56
27.87%
|
1.22
2.52%
|
1.19
23.96%
|
0.96
|
Solvability | ||||
Assets |
€
86K
-4.17%
|
€
90K
-18.49%
|
€
110K
12.58%
|
€
98K
|
Amounts payable |
€
39K
-22.43%
|
€
50K
-25.6%
|
€
68K
2.38%
|
€
66K
|
Solvability |
54.47%
24.5%
|
43.75%
13.99%
|
38.38%
19.01%
|
32.25%
|
Long term debt ratio |
0.10
-68.75%
|
0.32
-33.33%
|
0.48
-45.45%
|
0.88
|
Interest Coverage Ratio | ||||
Rentability | ||||
Gross profitability |
56.41%
198.94%
|
18.87%
-61.96%
|
49.6%
-4.69%
|
52.04%
|
Net profitability |
35.66%
567.98%
|
-7.62%
-130.04%
|
25.37%
34.8%
|
18.82%
|
Return On Assets (ROA) |
19.42
682.26%
|
-3.34
-134.25%
|
9.74
60.44%
|
6.07
|
Return On Equity (ROE) |
35.66
567.7%
|
-7.62
-130.05%
|
25.37
34.79%
|
18.82
|
Efficiency | ||||
Customer credit | ||||
Supplier credit | ||||
Inventory Turnover Ratio | ||||
Days Sales Outstanding (DSO) | ||||
Days Sales of Inventory (DSI) | ||||
Social balance | ||||
Employees |
Klaar om te starten?
Find out the financial situation of potential customers, suppliers or business partners by consulting official information and key figures.